Fair, but also to be fair this company looks to be doing rev growth %s beyond it's cost growth %s. Overall cost per quarter has been relatively stable in last 12 months (av around $2.25M a qtr) although staff and admin costs are only just increasing less than revenue growth as a percentage. They really need to turbocharge rev growth without increasing costs by too much to do so - otherwise it will be a long road to cashflow +ve and a lot of dilution in the meantime...
- Forums
- ASX - By Stock
- W2V
- Fishy’s 40 bagger
Fishy’s 40 bagger, page-269
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add W2V (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 197601 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 3519751 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 197601 | 0.008 |
4 | 1866000 | 0.007 |
10 | 4495176 | 0.006 |
4 | 1535000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 3519751 | 8 |
0.010 | 5492952 | 5 |
0.011 | 5026189 | 8 |
0.012 | 666583 | 2 |
0.014 | 200000 | 1 |
Last trade - 16.36pm 13/11/2024 (20 minute delay) ? |
Featured News
W2V (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online